Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) Director Atul Pande sold 1,500 shares of the business’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $38.01, for a total value of $57,015.00. Following the sale, the director owned 116,731 shares in the company, valued at $4,436,945.31. The [...]